⌘K

Login Start Free

Home/Filings/4/0001387131-21-005545

4//SEC Filing

GRANGE DAVID L 4

Accession 0001387131-21-005545

CIK 0001430306other

View on SEC.gov Company Profile

Filed

May 11, 8:00 PM ET

Accepted

May 12, 4:43 PM ET

Size

5.3 KB

Accession

0001387131-21-005545

Insider Transaction Report

Form 4

Period: 2021-05-10

Tonix Pharmaceuticals Holding Corp.TNXP

Director

Transactions

Award
Stock Option
2021-05-10+270,882→ 270,882 total
Exercise: $1.03From: 2022-05-10Exp: 2031-05-10→ Common Stock (270,882 underlying)

Footnotes (1)

[F1]The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.

Documents

1 file

4
ownership.xmlPrimary
GRANGE - CHANGES IN BENEFICIAL OWNERSHIP

Issuer

Tonix Pharmaceuticals Holding Corp.

CIK 0001430306

Entity typeother

Related Parties

1

filerCIK 0001264908

Filing Metadata

Form type: 4
Filed: May 11, 8:00 PM ET
Accepted: May 12, 4:43 PM ET
Size: 5.3 KB

View on SEC.gov